0.35c by March maybe even 0.44cI heard third hand that the...

0.35c by March maybe even 0.44c

I heard third hand that the directors were not looking happy at the AGM, would they like to attend another AGM under the same conditions as this year, I doubt it.

I doubt that BB would be allowed to make any promises, so I suspect the modus operandi is to promise nothing and SURPRISE to the upside.

Hence why we were told that there would only be an update on the FDA submission by years end.

Then we get surprised to learn that the FDA dossier had been submitted.

Surprised to the Upside

First placement of an APAS Independence into a US Lab was going to happen in 1st Quarter instead it happened in November this year

Surprised to the Upside.

LBT's focus right now must be to increase the share price so we are not sitting ducks.

The next 4 months news looking forward would look similar to this IMHO

Dr Labor completes APAS Independence evaluation.

Clinical trial commences for MRSA Module

4 New sales to large Australia Lab

LBT concludes APAS Clinical Trial program with Successful results in its Melbourne and German trial achieving a 98% sensitivity in its detection of disease-causing bacteria.

2 new sales to Dr Labor

510k Supplement submitted for MRSA module

Further sales of APAS Independence

FDA Approval granted for APAS Independence as a Class two medical device

Dr Labor to present at the 29th ECCMID "Image interpretation of MRSA cultures using APAS Independence"

Sales in addition to the FDA approval will move this share price forward over the next few months.

The buy on rumour sell on fact... in relation to the FDA approval should move the share price forward, it might even send it back to a dollar IMHO as traders have a party with it once we have approval and at least this time we have a product to sell not one that is 2 years away

We have two BDMs one in Australia and one in Germany that will be out to sell some units and support the distribution partner(s) when appointed.

The next four months will be interesting... all in my humble opinion only.